Dianthus Therapeutics Inc (DNTH)
25.70
+0.17
(+0.67%)
USD |
NASDAQ |
Jun 24, 16:00
25.46
-0.24
(-0.91%)
After-Hours: 20:00
Dianthus Therapeutics Profit Margin (Quarterly): -1.57K% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -1.57K% |
December 31, 2023 | -2.31K% |
September 30, 2023 | -1.60K% |
Date | Value |
---|---|
March 31, 2023 | -1.49K% |
December 31, 2022 | -860.9% |
September 30, 2022 | -663.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.31K%
Minimum
Dec 2023
-663.6%
Maximum
Sep 2022
-1.42K%
Average
-1.53K%
Median
Profit Margin (Quarterly) Benchmarks
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | -14.54K% |
IGC Pharma Inc | -2.74K% |
NovaBay Pharmaceuticals Inc | -122.2% |
Protalix BioTherapeutics Inc | -122.6% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -23.27% |
Return on Assets | -22.05% |
Return on Invested Capital | -23.27% |
Operating Margin (Quarterly) | -2.04K% |
Return on Net Operating Assets | -994.6% |